TrialInternational immunopharmacology2021

An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.

Ilad Alavi Darazam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.